Мировые
            Новости
!
Seo
  Home RSS Email Stat  
Seo
         Навигация
Информационный портал ! Информация.





Рейтинг@Mail.ru

Новости России

Общефедеральные

Мировые новости

в мире

Религия и общество


Политика

Экономика

Культура

Экология

Медицина

Происшествия

Интервью

Обзоры

Биографии

Общество

Статьи

Медиалогия

Архангельская обл.

Вологодская обл.

Калининградская обл.

Карелия

Коми

Ленинградская обл.

Мурманская обл.

Ненецкий АО

Новгородская обл.

Псковская обл.

Санкт-Петербург

Москва

Чечня

Новосибирская обл.

украина: политика

украина: события

технологии и наука

странности

мир о нас

шоу-biz

здоровье

бизнес

столица

мнение

Бизнес

Интернет

Телекоммуникации

Безопасность

Платформа

Цифрография

Цифровой дом

Ноутбуки и КПК

Принтеры

Софт и игры

Аналитика

Телефоны

Сети

exler

mazoo networks

Копирайтинговое

Все- про АдСенс

Софтфорум

Новости касперского

Про Первый

e-commerce

новости WM

Погода

blogica

Seo PPC FAQ

Doorway

Blog news

Internet Archive

Новые скрипты

Новые программы

Action Alerts

Advertising

Advice

Affiliate Programs

Architecture

Art & Entertainment: Country Music

Art & Entertainment: Magazines

Art & Entertainment: Music

Art & Entertainment: Television

Automotive: Aftermarket

Automotive: Motorcycle & Bike

Automotive: Racing

Automotive: Recreational Vehicle

Automotive: Trade Publications

Baby

Banner Networks

Blogging

Business

Business and Finance

Business: Markets

Intellectual Property Strategies for Pharmaceutical Development

Bharat Book Bureau, a leading market information distributor has put forth a report -
Intellectual Property Strategies for Pharmaceutical Development
"http://www.bharatbook.com/detail.asp?id=20136"

This report provides an introduction to the intellectual property strategies involved in the development of pharmaceuticals from the discovery of an NCE, through to its launch, with details and advice on the appropriate decisions and actions. The report also deals with the different types of inventions that may occur. According to Tufts University in 2003, a new chemical entity (NCE) costs on average US$897 million to develop, including cost of post-approval research (rising from US$803 M in 2001). An NCE can often be copied very easily once it is on the market.
Lesser, but still considerable costs apply to the development of new forms of an NCE, and to new formulations and uses of existing NCEs. To justify such investments the research-based industry, including those who develop new formulations and uses, needs exclusive rights for a reasonable period. This exclusivity allows the investors to recoup their costs, and, if they are lucky, the costs of their failed developments. If they are very lucky and skillful they may make a considerable amount of money.

For more information, Please visit :
http://www.bharatbook.com/detail.asp?id=20136

bharatbook.com, a leading information aggregator, facilitates and supports the business information needs for market research, corporate / strategic planning by
providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance,
risk management, country intelligence, consumer & durable goods, chemical and more. With over 90,000 reports, you can get instant access and insights on the studies in your areas of interest. For more information,
call at +91 22 27578668 / 27579438 or email
info@bharatbook.com or our website www.bharatbook.com

Page created in 0.05479 seconds |